It has been challenging to identify core neurocognitive deficits that are consistent across multiple studies in patients with Obsessive Compulsive Disorder (OCD). In turn, this leads to difficulty in translating findings from human studies into animal models to dissect pathophysiology. In this article, we use primary data from a working memory task in OCD patients to illustrate this issue.
t r a c t
It has been challenging to identify core neurocognitive deficits that are consistent across multiple studies in patients with Obsessive Compulsive Disorder (OCD). In turn, this leads to difficulty in translating findings from human studies into animal models to dissect pathophysiology. In this article, we use primary data from a working memory task in OCD patients to illustrate this issue.
Working memory deficiencies have been proposed as an explanatory model for the evolution of checking compulsions in a subset of OCD patients. However, findings have been mixed due to variability in task design, examination of spatial vs. verbal working memory, and heterogeneity in patient populations. Two major questions therefore remain: first, do OCD patients have disturbances in working memory? Second, if there are working memory deficits in OCD, do they cause checking compulsions?
In order to investigate these questions, we tested 19 unmedicated OCD patients and 23 matched healthy controls using a verbal working memory task that has increased difficulty/task-load compared to classic digit-span tasks. OCD patients did not significantly differ in their performance on this task compared to healthy controls, regardless of the outcome measure used (i.e. reaction time or accuracy). Exploratory analyses suggest that a subset of patients with predominant doubt/checking symptoms may have decreased memory confidence despite normal performance on trials with the highest working memory load.
These results suggest that other etiologic factors for checking compulsions should be considered. In addition, they serve as a touchstone for discussion, and therefore help us to generate a roadmap for increasing consensus in the assessment of neurocognitive function in psychiatric disorders.
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Introduction
An increasing number of psychiatric researchers are attempting to translate findings from humans into animals, in an effort to leverage animal models to dissect the molecular and cellular abnormalities that underlie deficits in core cognitive processes central to neuropsychiatric disorders. This strategy takes advantage of the strength of animal systems, including the recent development of technologies that allow precise activation and inhibition of specific neural circuits on a variety of timescales (i.e. optogenetics and chemogenetics) (Dong, Rogan, & Roth, 2010; Gradinaru et al., 2010; Mattis et al., 2012; Rogan & Roth, 2011; Schneider, Gradinaru, Zhang, & Deisseroth, 2008; Sparta et al., 2012; Zhang et al., 2010) , as well as the ability to regulate expression of genes of interest with spatial and temporal specificity (Donaldson & Hen, 2014; Donaldson, Nautiyal, Ahmari, & Hen, 2013) . With these tools we can now determine how abnormalities in specific neural circuits lead to changes in cognitive function. This information can be used to elucidate the potential neural mechanisms underlying similar cognitive abnormalities characteristic of neuropsychiatric disease in humans. However, to help bridge the gap between findings observed in animals and human neuropsychiatric illness, another important step is the identification of neurocognitive functions that are reliably abnormal in patient populations suffering from particular psychiatric illnesses. Despite significant efforts in this area, it remains challenging to identify consistently abnormal biomarkers within particular disease categories. Here, we will
